Wendy Pribanich
Family Medicine · Uniontown, OHNPI 1306359070
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 525 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,209, more than ten times the $205 reported in 2021. Among family medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 525 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$1K
- Novo Nordisk$874
- Pfizer$643
- Boehringer Ingelheim$552
- AstraZeneca$510
- plus $4K from 31 others
What the payments were for
- Food & beverage$8,31598%
- Education$2002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,061 |
| Lilly USA, LLC | 79 | $1,017 |
| Novo Nordisk | 60 | $874 |
| Pfizer | 42 | $643 |
| Boehringer Ingelheim | 31 | $552 |
| AstraZeneca | 29 | $510 |
| Astellas Pharma US Inc | 23 | $509 |
| GSK | 30 | $442 |
| Amgen | 32 | $417 |
| Abbott | 14 | $287 |
| Bayer | 17 | $263 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $167 |
| Otsuka America Pharmaceutical, Inc. | 2 | $149 |
| Aimmune Therapeutics, Inc. | 8 | $135 |
| Corcept Therapeutics | 6 | $130 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $118 |
| Exact Sciences | 6 | $116 |
| Nestle Healthcare Nutrition Inc. | 7 | $114 |
| Xeris Pharmaceuticals, Inc. | 5 | $100 |
| E.r. Squibb & Sons, L.L.C. | 6 | $96 |
| Verona Pharma, Inc. | 4 | $95 |
| Merck | 6 | $93 |
| Sanofi-aventis U.S. LLC | 6 | $90 |
| Lundbeck LLC | 5 | $87 |
| Antares Pharma, Inc. | 4 | $70 |
| IBSA Pharma Inc. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Novartis | 2 | $39 |
| Evoke Pharma, Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $28 |
| Boston Scientific | 1 | $28 |
| Johnson & Johnson | 1 | $24 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Ascensia Diabetes Care US Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$119
How this compares
$8,515 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 58 | $53,431 |
| EliquisApixaban | 31 | $36,697 |
| OzempicSemaglutide | 26 | $24,826 |
| FarxigaDapagliflozin Propanediol | 26 | $23,666 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $21,401 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 30 | $16,702 |
| MounjaroTirzepatide | 12 | $14,070 |
| MyrbetriqMirabegron | 14 | $11,738 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,375 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,682 |
| Semglee (Yfgn) PenInsulin Glargine-Yfgn | 11 | $4,006 |
| Doxepin Hcl | 17 | $2,796 |
| Omeprazole | 154 | $2,412 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $2,242 |
| Levothyroxine Sodium | 118 | $1,683 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $552 | $65,48782 claims |
| PfizerEliquis | $643 | $36,69731 claims |
| Novo NordiskOzempic | $874 | $24,82626 claims |
| AstraZenecaFarxiga | $510 | $23,66626 claims |
| GSKTrelegy Ellipta | $442 | $21,40127 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $90 | $16,70230 claims |
| Lilly USA, LLCMounjaro | $1,017 | $14,07012 claims |
| Astellas Pharma US IncMyrbetriq | $509 | $11,73814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Uniontown
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.